Protocolo diabetes mellitus tipo 2 - Sociedad Española de Diabetes

FMC – Protocolos
141. Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry
KB, Colen LB, and the Diabetic Neuropathy Study Group.
Diabetic neuropathies. Diabetes Care 1992; 15: 1926-1975
142. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen
PH. A multicentre study of the prevalence of diabetic
peripheral neuropathy in the United Kingdom hospital clinic
population. Diabetologia 1993; 36: 150-154.
143. Ziegler D. Diagnosis and management of diabetic peripheral
neuropathy. Diabet Med 1996; 13 (Supl 1): 34-38 .
Pie diabético
144. American Diabetes Association. Consensus statement: diabetic
foot wound care. Diabetes Care 1999; 22: 1354-1360.
145. Armstrong D, Harkless D. Outcomes of preventative care
in a diabetic foot specialty clinic. J Foot Ankle Surg 1998;
37: 460-466.
146. Armstrong D, Lavery L, Harkless L. Validation of a diabetic
wound classification system. Diabetes Care 1998; 21:
855-881.
147. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW,
Karchmer AW. Assesment and management of foot disease
in patients with diabetes. N Engl J Med 1994; 331: 854-
860.
148. Gimbert RM, Méndez A, Llussa J, Tomás P, Cano JF, Roura
P, and the GEDAPS Group. Diabetic foot in primary health
care. Diabetología 1997; 40 (Supl 1): 467.
149. Llussa J, Tomas P, Méndez A, Gimbert RM, Bundó M, Cano
JF, and the GedapS group. Insensibility to the 5.07 Monofilament
in non insulin dependent diabetics. Diabetologia
1997; 40 (Supl 1): 485.
150. Mayfield J, Reiber G, Sanders L, Janisse D, Pogach L. Preventive
foot care in people with diabetes. Diabetes Care
1998; 21: 2161-2177.
151. Olmos PR, Cataland S, O’Dorisimo TM, Casey C, Simon
S. The Semmes-Weinstein monofilament as a potential predictor
of foot ulceration in patients with non-insulindependent-diabetes.
Am J Med Sci 1995; 309: 76-82.
152. Ramsey SD, Sandhu N, Newtoon K, Reiber GE, Blough D,
Wagner EH, McCulloch DK. Incidence, outcomes and cost
of foot ulcers in patients with diabetes. Diabetes Care
1999; 22: 382-387.
153. Rith-Najarian SS. Identifiying diabetic patients at high risc
for lower extremity amputation in a primary health setting.
Diabetes Care 1992; 15: 1386-1389.
Vacunaciones
154. American Diabetes Association. Position statement: inmunization
and the prevention of influenza and pneumococcal
disease in people with diabetes. Diabetes Care 2000; 23
(Supl 1): 91-93.
Educación
155. Clement S. Diabetes self-management education (technical
review). Diabetes Care 1995; 18: 1204-1214.
156. Dalmau M, Sebastià C. Educació diabetològica pas a pas.
Guia pràctica per a la consulta d’infermeria. Madrid: Jarpyo
Editores, 1999.
157. Diabetes Education Study Group. Kit de supervivencia. Estrategias
educativas de 5 minutos. Madrid: Novocare. NovoNordisk,1995.
158. Eramo-Melkus GA, Wylie-Roset J, Hagan JA. Metabolic
impact of education in NIDDM. Diabetes Care 1992; 16:
1453-1458.
159. Espluga Capdevila A, Trilla Soler M. Diabetes mellitus
tipo 2. Manual de educación sanitaria para equipos de
atención primaria. Madrid: Novo Nordisk. Pharma S.A.,
1995.
160. Funnell MM, Haas LB. National standards for diabetes
self-management education programs (technical review).
Diabetes Care 1995; 18: 100-116.
161. Figuerola D. Diabetes (2.ª ed.). Barcelona: Masson-Salvat,
1990.
162. Glasgow RE, Osteen VL. Evaluating diabetes education.
Diabetes Care 1992; 15: 1423-1432.
163. Guidelines for education programmes. En: Krans HMJ,
Porta M, Keen H, editores. Diabetes care and research in
Europe. The Saint Vincent Declaration Action Programme.
Copenhague: WHO Regional Office for Europe, 1992.
164. Street RL, Piziak VK, Carpentier WS, Herzog J, Hejl J,
Skinner G, McLellan L. Provider-patient communication
and metabolic control. Diabetes Care 1993; 16: 714-721.
54